|

Budesonide/Glycopyrronium/Formoterol Fumarate Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Hyperinflation1
  • Heart Disease1
  • Chronic Obstructive Pulmonary Disease1
  • COPD1

Other1 trial

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.